Expression, Tissue Distribution and Function of miR-21 in Esophageal Squamous Cell Carcinoma

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Nouraee, Nazila ^a,b   Van Roosbroeck, Katrien ^b   Vasei, Mohammad ^c   Semnani, Shahriar ^d   Samaei, Nader Mansour ^d   Naghshvar, Farshad ^e   Omidi, Abbas Ali ^f   Calin, George A ^b   Mowla, Seyed Javad ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; MICRORNA 21; PROTEIN COL4A1; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GRADING; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CYTOPLASM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FIBROBLAST; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE DISTRIBUTION; TUMOR MICROENVIRONMENT; UPREGULATION;

BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; COCULTURE TECHNIQUES; COLLAGEN TYPE IV; CULTURE MEDIA, CONDITIONED; ESOPHAGEAL NEOPLASMS; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICRORNAS; NEOPLASM GRADING; ORGAN SPECIFICITY; TISSUE INHIBITOR OF METALLOPROTEINASE-3; UP-REGULATION;

EID: 84883818845     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073009     Document Type: Article

References (56)

1. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi P, (2011) A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language. Cell 146: 353-358.
2. Delgado M, Leon J, (2006) Gene expression regulation and cancer. Clin Transl Oncol 8 (11): 780-787.
3. Bartel D, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
4. Liao J, Ma L, Guo Y, Zhang Y, Zhou H, et al. (2010) Deep Sequencing of Human Nuclear and Cytoplasmic Small RNAs Reveals an Unexpectedly Complex Subcellular Distribution of miRNAs and tRNA 3' Trailers. PLoS ONE 5 (5): e10563.
5. Pang J, Kwok W, Chen Z, Ng H, (2009) Oncogenic role of microRNAs in brain tumors. Acta Neuropathologica 117 (6): 599-611.
6. Schetter A, Leung S, Sohn J, Zanetti K, Bowman E, et al. (2008) MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma. JAMA 299 (4): 425-436.
7. Volinia S, Calin G, Liu C, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
8. Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M, (2008) MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival. J Gastrointest Surg 12: 2171-2176.
9. Esquela-Kerscher A, Slack F, (2006) Oncomirs: MicroRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
10. Mori Y, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, et al. (2009) MicroRNA-21 induces cell proliferation and invasion in esophageal squamous cell carcinoma. Mol Med Reports 2: 235-239.
11. Selcuklu S, Donoghue M, Spillane C, (2009) miR-21 as a key regulator of oncogenic processes. Biochemical Society Transactions 37 (4): 918-925.
12. Chan J, Krichevsky A, Kosik K, (2005) MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells. Cancer Res 65 (14): 6029-6033.
13. Feber A, Xi L, Luketich J, Pennathur A, Landreneau R, et al. (2008) MicroRNA Expression Profiles of Esophageal Cancer. J Thorac Cardiovasc Surg 135 (2): 255-260.
14. Yang Y, Pan X, Lei W, Wang J, Song J, (2006) Transforming growth factor-b1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism. Oncogene 25: 7235-7244.
15. Zhang A, Liu Y, Shen Y, Xu Y, Li X, (2011) miR-21 Modulates Cell Apoptosis by Targeting Multiple Genes in Renal Cell Carcinoma. Urology 78 (2) 474: e13-19.
16. Hiyoshi Y, Kamohara H, Karashima R, Sato N, Imamura Y, et al. (2009) MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell Carcinoma. Clin Cancer Res 15 (6): 1915-1922.
17. Garzon R, Marcucci G, Croce C, (2010) Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9 (10): 775-789.
18. Alder H, Taccioli C, Chen H, Jiang Y, Smalley K, et al. (2012) Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis 33 (9): 1736-1744.
19. Wentz-Hunter K, Potashkin J, (2011) The Role of miRNAs as Key Regulators in the Neoplastic Microenvironment. Mol Biol Int 2011: 1-8.
20. Nielsen B, Jorgensen S, Fog J, Sokilde R, Christensen I, et al. (2011) High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 28 (1): 27-38.
21. Rask L, Balslev E, Jorgensen S, Eriksen J, Flyger H, et al. (2011) High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. Acta Pathologica, Microbiologica et Immunologica Scandinavica 119: 663-673.
22. Zhu S, Si M, Wu H, Mo Y, (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282 (19): 14328-14336.
23. Gabriely G, Wurdinger T, Kesari S, Esau C, Burchard J, et al. (2008) MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28 (17): 5369-5380.
24. Song B, Wang C, Liu J, Wang X, Lv L, et al. (2010) MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J Exp Clin Cancer Res 29: 29-36.
25. Cottonham C, Kaneko S, Xu L, (2010) miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem 285 (46): 35293-35302.
26. Davis B, Hilyard A, Lagna G, Hata A, (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454 (7200): 56-61.
27. Song J, (2007) EMT or apoptosis: a decision for TGF-β. Cell Res 17: 289-290.
28. Willis B, Borok Z, (2007) TGF-b-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 293: L525-L534.
29. Tejani M, Burtness B, (2012) Multi-Modality Therapy for Cancer of the Esophagus and GE Junction. Curr Treat Options Oncol 13: 390-402.
30. Vallbohmer D, Brabender J, Metzger R, Holscher A, (2010) Genetics in the Pathogenesis of Esophageal Cancer: Possible Predictive and Prognostic Factors. J Gastrointest Surg 1: 75-80.
31. Islami F, Kamangar F, Nasrollahzadeh D, Moller H, Boffetta P, et al. (2009) Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - A review. Eur J Cancer 45: 3156-3165.
32. McPherson RA, Pincus MR (2011) Henry' s clinical diagnosis and management by laboratory methods. Philadelphia: Saunder/Elsevier. 1528p.
33. Cirri P, Chiarugi P, (2011) Cancer associated fibroblasts: the dark side of the coin. American Journal of Cancer Research 1 (4): 482-497.
34. Bozoky B, Savchenko A, Csermely P, Korcsmaros T, Dul Z, et al. (2013) Novel signatures of cancer-associated fibroblasts. International journal of cancer 133 (2): 286-293.
35. Kalluri R, Zeisberg M, (2006) Fibroblasts in cancer. Nature Reviews 6: 392-401.
36. Sugimoto H, Mundel T, Kieran M, Kalluri R, (2006) Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 5 (12): 1640-1646.
37. Saadi A, Shannon N, Lao-Sirieix P, O' Donovan M, Walker E, et al. (2010) Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers. Proc Natl Acad Sci USA 107 (5): 2177-2182.
38. Mathe E, Nguyen G, Bowman E, Zhao Y, Budhu A, et al. (2009) MiRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus and associations with survival. Clin Cancer Res 15 (19): 6192-6200.
39. Yang H, Gu J, Wang K, Zhang W, Xing J, et al. (2009) MicroRNA Expression Signatures in Barrett's Esophagus and Esophageal Adenocarcinoma. Clin Cancer Res 15: 5744-5752.
40. Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, et al. (2010) Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncology reports 23: 1625-1633.
41. Akagi I, Miyashita M, Ishibashi O, Mishima T, Kikuchi K, et al. (2011) Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. Dis Esophagus 24: 523-530.
42. Wu B, Xu L, Du Z, Liao L, Zhang H, et al. (2011) MiRNA profile in esophageal squamous cell carcinoma: Downregulation of miR-143 and miR-145. World J Gastroenterol 17 (1): 79-88.
43. Patnaik S, Mallick R, Yendamuri S, (2010) MicroRNAs and esophageal cancer. J Gastrointest Oncol 1 (1): 55-63.
44. Jorgensen S, Baker A, Moller S, Nielsen B, (2010) Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 52: 375-381.
45. Yamamichi N, Shimomura R, Inada K, Sakurai K, Haraguchi T, et al. (2009) Locked Nucleic Acid In situ Hybridization Analysis of miR-21 Expression during Colorectal Cancer Development. Clin Cancer Res 15: 4009-4016.
46. Qi L, Bart J, Tan L, Platteel I, Van der Sluis T, et al. (2009) Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer 9: 163-170.
47. Yang C, Yue J, Pfeffer S, Handorf C, Pfeffer L, (2011) MicroRNA-21 regulates the metastatic behavior of B16 melanoma cells. J Biol Chem 286 (45): 39172-39178.
48. Fabbri M, Paone A, Calore F, Galli R, Gaudio E, et al. (2012) MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. PNAS 109 (31): E2110-E2116.
49. Wang N, Zhang CQ, He JH, Duan XF, Wang YY, et al. (2013) miR-21 Down-Regulation Suppresses Cell Growth, Invasion and Induces Cell Apoptosis by Targeting FASL, TIMP3, and RECK Genes in Esophageal Carcinoma. Dig Dis Sci 58 (7): 1863-1870.
50. Yang X, Wang J, Guo SL, Fan KJ, Li J, et al. (2011) miR-21 promotes keratinocyte migration and re-epithelialization during wound healing. Int J Biol Sci 7 (5): 685-690.
51. Mase Y, Ishibashi O, Ishikawa T, Takizawa T, Kiguchi K, et al. (2012) MiR-21 is enriched in the RNA-induced silencing complex and targets COL4A1 in human granulosa cell lines. Reprod Sci 19 (10): 1030-1040.
52. Selaru F, Olaru A, Kan T, David S, Cheng Y, et al. (2009) MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology 49 (5): 1595-1601.
53. Bierie B, Moses H, (2006) TGFβ: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6 (7): 506-520.
54. Stover D, Bierie B, Moses H, (2007) A delicate balance: TGF-beta and the tumor microenvironment. J Cell Biochem 101 (4): 851-861.
55. Mandinova A, Atar D, Schafer BW, Spiess M, Aebi U, et al. (1998) Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J. Cell Sci 111: 2043-2054.
56. Herrera M, Herrera A, Dominguez G, Silva J, Garcia V, et al. (2013) Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients. Cancer Sci 104 (4): 437-444.